Outlook Therapeutics, Inc. - Common Stock (OTLK)
0.7300
-0.0100 (-1.35%)
NASDAQ· Last Trade: May 29th, 7:28 PM EDT
On Friday, there are stocks with unusual volume. Let's take a look.chartmill.com
Via Chartmill · May 29, 2026
Discover the most active stocks in Thursday's session.chartmill.com
Via Chartmill · May 28, 2026
Most active stocks in Tuesday's sessionchartmill.com
Via Chartmill · May 26, 2026
Top stock movements in today's session.chartmill.com
Via Chartmill · May 26, 2026
Gapping stocks in Tuesday's sessionchartmill.com
Via Chartmill · May 26, 2026
Which stocks are moving before the opening bell on Tuesday?chartmill.com
Via Chartmill · May 26, 2026
What's going on in today's after hours sessionchartmill.com
Via Chartmill · May 21, 2026
These stocks are moving in today's sessionchartmill.com
Via Chartmill · March 24, 2026
Top movers in Tuesday's sessionchartmill.com
Via Chartmill · March 24, 2026
There are notable gap-ups and gap-downs in today's session.chartmill.com
Via Chartmill · March 24, 2026
Which stocks are moving before the opening bell on Tuesday?chartmill.com
Via Chartmill · March 24, 2026
What's going on in today's after hours sessionchartmill.com
Via Chartmill · March 23, 2026
Unusual volume stocks in Wednesday's sessionchartmill.com
Via Chartmill · January 7, 2026
Let's take a look at the stocks that are in motion in today's session.chartmill.com
Via Chartmill · January 5, 2026
Keep an eye on the top gainers and losers in Monday's session.chartmill.com
Via Chartmill · January 5, 2026
Top stock movements in today's session.chartmill.com
Via Chartmill · January 2, 2026
Discover the most active stocks in Friday's session.chartmill.com
Via Chartmill · January 2, 2026
In today's session, these stocks are experiencing unusual volume.chartmill.com
Via Chartmill · January 2, 2026
Top movers analysis in the middle of the day on 2026-01-02: top gainers and losers in today's session.chartmill.com
Via Chartmill · January 2, 2026
Friday's session: gap up and gap down stockschartmill.com
Via Chartmill · January 2, 2026
What's going on in today's pre-market sessionchartmill.com
Via Chartmill · January 2, 2026
The U.S. health regulatory agency, the FDA, rejected Outlook Therapeutics’ application for approval of its drug Lytenava, which is intended to treat wet AMD.
Via Stocktwits · January 2, 2026
Get insights into the top gainers and losers of Thursday's after-hours session.chartmill.com
Via Chartmill · January 1, 2026
Wondering what's happening in today's after-hours session?chartmill.com
Via Chartmill · December 31, 2025